Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

enGene Therapeutics Inc.

NASDAQ: ENGN · Life Sciences · 2 alerts · CIK 1980845

Share price
$1.89Close, Nov 16
Market cap
$127M
Shares outstanding
67.02MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All enGene Therapeutics Inc. filings on SEC EDGAR ↗

4:41 PM ET Form 4
Insider Buying

enGene Therapeutics Interim CMO William Grossman Buys $10.1K of Stock

William Grossman, Interim CMO, bought 5,102 shares of enGene Therapeutics Inc. at $1.97 a share, worth $10.1K in total on Sep 22, 2026. Shares held after the trade: 5,102.

Value
$10.1K
Shares
5,102
Price
$1.97
Role
Interim CMO
Trade date
Sep 22, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.